Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -33

Accepted - Volume 3

Comment Record
Commentor Mr. John Buder Date/Time 2002-11-01 12:30:34
Organization International Network for History of Public Health
Category Individual

Comments for FDA General
1. General Comments In the event of a deliberate smallpox bioattack using concentrated aerosols released clandestinely in closed, poorly ventilated spaces occupied by large numbers of people, we should be anticipating a far higher than 30 percent proportion of infections sufficiently massive to result in the typically fatal flat and hemorrhagic forms, certainly among those born after 1972 who have no immunity. John Buder

EC -33